Is Fabre-Kramer’s Gepirone Antidepressant Rising From The Dead After 8 Years?
This article was originally published in The Pink Sheet Daily
Executive Summary
Nothing has been heard about the major depressive disorder treatment since FDA issued a third “not approvable” letter in 2007; advisory committee to discuss NDA in December.